Pathology of Ischaemic Brain Damage — Implications for Therapy

  • W. Meier-Ruge
  • D. Theodore
  • J. Abraham
Part of the Advances in Behavioral Biology book series (ABBI, volume 35)


An ischaemic infarct was produced in primates by applying a clip to the right middle cerebral artery. Enzyme histochemical data are presented, documenting the development of a focal ischaemic brain lesion. The relatively slow demarcation of the ischaemic brain infarct appears to be correlated with the efficiency of the collateral blood supply. The extent of the collateral blood supply is documented by morphometric data on the brain capillaries. It was evident that effective intervention in the infarction process with a view to limiting the extent of an ischaemic brain lesion is possible only at an early stage. A reduction of blood viscosity by bloodletting and haemodilution is the most important measure to be taken in the first few hours after a stroke. The second important step in the treatment of acute stroke is inhibition of blood platelet aggregation to arrest the thrombotic process and avoid complete occlusion of the artery, or in the case of an embolism to limit the extent of the infarct.


Middle Cerebral Artery Caudate Nucleus Packed Cell Volume Lentiform Nucleus Ischaemic Brain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. v. Albert, H.H., 1983, Sofortmassnahmen beim Schlaganfall nicht nur für das Ueberleben entscheidend, Notfallmedizin 9: 505–515Google Scholar
  2. Apte, C.A., Theodore, D.R. and Abraham, J., 1985, Temporal profile of platelet aggregation following experimentally induced acute cerebral ischaemia, Indian J. Med. Res. 81: 613–617Google Scholar
  3. Astrup, J., Symon, L., Branston, N.M. and Lassen, N.A., 1977, Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischaemia, 8: 51–57Google Scholar
  4. Bauer, R.B. and Tellez, H., 1973, Dexamethasone as treatment in cerebrovascular disease. A controlled study in acute cerebral infarction, Stroke 4: 547–555CrossRefGoogle Scholar
  5. Britton, M., Carlsson, A. and de Faire, U., 1986, Blood pressure course in patients with acute stroke and matched controls, Stroke 17: 861–864CrossRefGoogle Scholar
  6. Burke, A.M., Younkin, D., Gordon, J., Goldberg, H., Graham, T., Kushner, M., Obrist, W., Jaggi, J., Rosen, M. and Reivich, M., 1986, Changes in cerebral blood flow and recovery from acute stroke, Stroke 17: 173–178CrossRefGoogle Scholar
  7. Fouque, F. and Vargaftig, B.B., 1985, Synergie entre l’adrénaline et le PAF-acüther sur la plaquette humaine: interfürence de l’Hydergine, J. Pharmacol. (Paris), 16: Suppl. III, 145–151Google Scholar
  8. Garcia, J.H., 1983, Ischemic injuries of the brain, Arch. Pathol. Lab. Med. 107: 157–161Google Scholar
  9. Garcia, J.H., 1984, Experimental ischemic stroke: A review, Stroke 15: 5–14CrossRefGoogle Scholar
  10. Gerber, A., Weidmann, P. and Laederach, K., 1986, Cardiovascular regulation during administration of co-dergocrine to normal subjects, Lamp. J. clin.Phan macol. 29: 565–572CrossRefGoogle Scholar
  11. Grotta, J.C., 1987, Can raising cerebral blood flow improve outcome after acute cerebral infarction? Stroke 18: 264–267CrossRefGoogle Scholar
  12. Grotta, J.C., Pettigrew, L.C., Allen, S., Tonnesen, A., Yasu, F.M., Gray, J. and Spydell, J., 1985, Baseline hemodynamic state and response to hemodilution in patients with acute cerebral ischemia, Stroke 16: 790–795CrossRefGoogle Scholar
  13. Guffanti, E., Vaccarella, A., Meregalli, M., Fiorella, G., Chierichetti, S.M. and Mazzola, C., 1985, A single blind comparison of dihydroergotoxine mesylate and clonidine for treatment of hypertensive emergencies, Int. J. clin. Pharmacol. Ther. Toxicol. 23: 506–509Google Scholar
  14. Guiraud-Chaumeil, B., Rascal, A., David, J., Bonen, B., Clanet, M. and Bierme, R., 1982, Prévention des récidives des accidents vasculaire cérébraux ischémiques par les antiaarégar.ts plaquettaires, Rev. Neurol. (Paris) 138: 367–385Google Scholar
  15. Gygax, P., Meier-Ruge, W., Schulz, U. and Enz, A., 1976, Experimental studies on the action of metabolic and vasoactive substances in the oligemically disturbed brain, Arzneimittel-Forsch. 26: 1245–1246Google Scholar
  16. Gygax, P. and Wiernsberger, N., 1982, Hypotension induced changes in cerebral microflow and EEG and their pharmacological alterations, Acta Medica Scandinavica 678: (Suppl.), 29–36Google Scholar
  17. Heiss, W.D., 1986, Ansatzpunkte zur Therapie zerebraler Durch- blutungsstörungen, Dtsch. med. Wschr. 111: 186–191CrossRefGoogle Scholar
  18. Heiss, W.D. and Rosner, G., 1983, Duration versus severity of ischemia as critical factors of cortical cell damage, Cerebrovascular Diseases, ed. M. Reivich, H.I. Hurtig, pp. 225–233, Raven Press, N.Y.Google Scholar
  19. Heuser, D. and Guggenberger, H., 1985, Ionic changes in brain ischaemia and alterations produced by drugs, Brit. J. Anaesth. 57: 23–33CrossRefGoogle Scholar
  20. Hirsch, J., 1985, Progress Review: The relationship between dose of aspirin, side-effects and antithrombotic effectiveness, Stroke 16: 1–4CrossRefGoogle Scholar
  21. Holmes, J.B., 1979, Potentiating effect of adrenalin on adenosine diphosphate-induced reduction in rabbit circulating platelet count: Inhibition by dihydroergotoxine, Thrombos. Haemostas. (Stuttgart) 42: 641–648Google Scholar
  22. Keller, T.S., 1987, Hypervolemic hemodilution after stroke, Stroke 18: 777Google Scholar
  23. Lechner, H., Ott, E. and Bertha, G., 1983, Therapeutical aspects of cerebrovascular disease, Eur. Neurol. 22: 74–77CrossRefGoogle Scholar
  24. Muizelaar, J.P., Wei, E.P., Kontos, H.A. and Becker, D.P., 1986, Cerebral blood flow is regulated by changes in blood pressure and in blood viscosity alike, Stroke 17: 44–48CrossRefGoogle Scholar
  25. Meier-Ruge, W., Theodore, D. and Abraham, J., 1987, Enzymehistochemical investigation of the pathogenesis of ischaemic brain lesions in primates and its clinical consequences, Stroke and Microcirculation, ed. J. CervdsNavarro, R. Ferszt, pp. 35–38, Raven PressGoogle Scholar
  26. Norris, J.W. and Hachinski, V.D., 1985, Megadose steroid therapy in ischemic stroke, Stroke 16: 150 (Abstr.)Google Scholar
  27. Ott, E., Lechner, H. and Fazekas, F., 1983, Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency, Eur. Neurol. 22: (Suppl. 1) 105–107CrossRefGoogle Scholar
  28. Sinzinger, H., 1985, Double blind study of the influence of co-dergocrine on platelet parameters in healthy volunteers, Europ. J. clin. Pharmacol. 28: 713–716CrossRefGoogle Scholar
  29. Strand, T., Asplund, K., Eriksson, S., Hagg, E., Lothner, F. and Wester, P., 1984, A randomized controlled trial of hemodilution therapy in acute ischemic stroke, Stroke 15: 980–984CrossRefGoogle Scholar
  30. Taylor, D.W., Sackett, D.L. and Haynes, R.B., 1984, Sample size for randomized trails in stroke prevention. How many patients do we need?, Stroke 15: 968–971CrossRefGoogle Scholar
  31. Thomas, D.J., Du Boulay, D.H., Marshall, J., Pearson, T.C., Russel Ross, R.W., Symon, L., Wetherley-Mein, G. and Zilkha, E., 1977, Effect of haematocrit on cerebral blood flow in man, Lancet 1977/II, 941–943Google Scholar
  32. Weth, G., 1984, Clinical, endocrinological and biochemical effects of co-dergocrine mesylate in antihypertensive crisis in aged patients, Europ. Heart J. 5: (Suppl I), 333, Abstr. No. 1618Google Scholar
  33. Wood, J.H. and McKee, D.B., 1985, Hemorheology of the cerebral circulation in stroke, Stroke 16: 765–772CrossRefGoogle Scholar
  34. Wood, J.H., Simeone, F.A., Fink, E.A. and Golden, M.A., 1983, Hypervolemic hemodilution in experimental focal cerebral ischemia. Elevation of cardiac output, regional cortical blood flow, and ICP after intravascular volume expansion with low molecular weight dextran, J. Neurosurg. 59: 500–509CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • W. Meier-Ruge
    • 1
  • D. Theodore
    • 2
  • J. Abraham
    • 2
  1. 1.Department of Pathology, Division of Gerontological Brain Research, Medical FacultyUniversity of BaselBaselSwitzerland
  2. 2.Department of Neurological SciencesChristian Medical CollegeVellore, Tamil NaduIndia

Personalised recommendations